Examining Stripes on a Herd of Zebras: Impact of Genomic Matching for Ultrarare Sarcomas in Phase 1 Clinical Trials (SAMBA 102).
Justin Tyler MoyersRoberto Carmagnani PestanaJason RoszikDavid S HongAung NaingSiqing FuSarina A Piha-PaulTimothy Anthony YapDaniel D KarpJordi Rodon AhnertJonathan A LivingstonMaria Alejandra ZarzourVinod RaviShreyaskumar R PatelRobert S BenjaminJoseph A LudwigCynthia E HerzogRavin RatanNeeta SomaiahAnthony P ConleyRichard G GorlickFunda Meric-BernstamVivek SubbiahPublished in: Clinical cancer research : an official journal of the American Association for Cancer Research (2022)
The results demonstrate the benefit of genomic selection in Phase 1 trials to help identify molecular subsets likely to benefit from targeted therapy.